Sunday November 8 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Chronogen, Inc.

With an aging population, the prevalence of age-related diseases is expected to mount rapidly over the next decade and new drugs are needed. Cardiovascular and metabolic diseases, cancer, neurodegenerative diseases represent huge markets that Biotech and Pharma companies are targeting.
Initially, Chronogen has focused all activities on the identification and the characterization of longevity target genes, cloned by means of long-lived mutants of the nematode C. elegans. For those genes that were also found to be expressed in human cells, Chronogen has developed a series of proprietary technologies and screening assays aimed at the identification of small molecule modulators mimicking the genetic effects obtained in C. elegans mutants, or equivalent mouse models. Efforts are now focused on the development of drug candidates, selected through unique screening assays, which modulate the production of molecules responsible for cardiovascular, metabolic and central nervous system diseases: Reactive Oxygen Species (ROS) in oxidative stress and Low density Lipoprotein (LDL) in dyslipidemia. Headquartered in Montreal, Canada, Chronogen now employs over 25 scientists.


Contact Details:
2901 Rachel E. Suite 22
Montreal
Quebec
H1W 4A4
Canada
Tel:1 514-521-9595
Fax:1 514-521-1579
Email:info@chronogen.com
WWW:

www.chronogen-inc.com/




Loading...

BioNews Results for Chronogen, Inc.:

Guru Stocks at 52-Week Low: Gilead Sciences Inc, Monsanto Company, Ralcorp Holdings Inc, MetroPCS Communicatio
Guru Focus:  Nov 1 2009 5:58PM Matching: inc
Guru Stocks At 52-Week Low: GILD, MON, RAH, PCS, LEAP
Guru Focus:  Nov 1 2009 5:51PM Matching: inc
Biotechnology Business: Research on biotechnology business reported by scientists at Amgen, Inc.
NewsRX:  Nov 1 2009 6:19AM Matching: inc
Expo at BioWest 2009 Showcases New Technology, Products and Services for the Regions Robust Bioscience Industry
PR.com:  Oct 31 2009 1:26PM Matching: inc
Lexicon Genetics Inc. Reports Operating Results (10-Q)
Guru Focus:  Oct 31 2009 6:11AM Matching: inc
Promote your company here: BioNewsCast - Press Release Distribution

View more Chronogen, Inc. news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 2797 times since April 2007, the link to the organisation's website has been followed 836 times

Recent Search Terms used to find this page: Chronogen Inc. | Chronogen | chronogen | Chronogene | chronogen inc | chronogen | chronogen | chronogen inc. | chronogen inc. | chronogen | .

Search for more companies in Montreal

Search for more companies in Quebec



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Chronogen, Inc.

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.